You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Details for Patent: 8,686,034


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,686,034 protect, and when does it expire?

Patent 8,686,034 protects HORIZANT and is included in one NDA.

This patent has thirty patent family members in twenty-three countries.

Summary for Patent: 8,686,034
Title:Crystalline form of .gamma.-aminobutyric acid analog
Abstract: A crystalline form of a .gamma.-aminobutyric acid analog, and methods of preparing same, are provided.
Inventor(s): Estrada; Tono (Santa Clara, CA), Raillard; Stephen P. (Mountain View, CA), Frauenfelder; Christine (Glis, CH), Zacher; Uwe (Brig, CH)
Assignee: XenoPort, Inc. (Santa Clara, CA)
Application Number:13/164,620
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,686,034: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape effectively. This article will delve into the details of United States Patent 8,686,034, focusing on its scope, claims, and the broader patent landscape.

Overview of United States Patent 8,686,034

Patent Title and Abstract

United States Patent 8,686,034, titled "Crystalline form of γ-aminobutyric acid analog," pertains to a specific crystalline form of a γ-aminobutyric acid (GABA) analog and methods for its preparation. The patent describes the physical and chemical properties of this crystalline form, which is significant for pharmaceutical applications[5].

Scope of the Patent

Technical Field

The patent falls within the technical field of pharmaceutical chemistry, specifically focusing on the synthesis and characterization of crystalline forms of GABA analogs. This field is critical for developing new drugs and improving existing ones.

Background of the Invention

The background section of the patent typically discusses the existing state of the art and the problems that the invention aims to solve. In this case, the patent likely addresses the need for stable and bioavailable forms of GABA analogs, which are important for neurological and psychiatric treatments.

Claims of the Patent

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of protection. For US Patent 8,686,034, the claims would include:

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, an independent claim might describe the crystalline form of the GABA analog and its method of preparation.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. For instance, a dependent claim might specify particular conditions or steps in the preparation method[5].

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial for determining the scope of protection and for infringement analysis. The claims in US Patent 8,686,034 would be constructed based on the language used, the specification, and any relevant prosecution history.

Patent Landscape Analysis

Prior Art and Related Patents

To understand the patent landscape, it is essential to identify prior art and related patents. This involves searching databases such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and other international patent databases[1].

Global Dossier and International Filings

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in identifying similar patents filed in other jurisdictions and understanding the global patent family[1].

Citation Data

The Common Citation Document (CCD) application consolidates prior art cited by multiple patent offices for the same invention. This tool can help in identifying key prior art and understanding how different offices have treated similar inventions[1].

Economic and Statistical Analysis

Patent Allowance Rates

Understanding the probability of receiving a patent can provide insights into the competitiveness of the field. Studies on patent allowance rates, such as those conducted by the USPTO, can help in estimating the likelihood of patent approval for similar inventions[4].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and published applications. This dataset can be used to analyze trends in patent scope and claim construction within the pharmaceutical chemistry field[3].

Practical Implications

Infringement and Litigation

Understanding the scope and claims of US Patent 8,686,034 is crucial for avoiding infringement. Companies and researchers must ensure that their own developments do not infringe on the protected claims of this patent.

Licensing and Collaboration

The patent landscape analysis can also inform licensing and collaboration strategies. Identifying key players and their patent portfolios can facilitate partnerships and licensing agreements.

Tools and Resources for Patent Search

USPTO Resources

The USPTO offers several tools for patent searching, including the Patent Public Search tool, the Public Search Facility, and Patent and Trademark Resource Centers (PTRCs). These resources are invaluable for conducting thorough patent searches[1].

International Databases

Access to international patent databases, such as those provided by the European Patent Office, Japan Patent Office, and World Intellectual Property Organization (WIPO), is essential for a comprehensive patent landscape analysis[1].

Key Takeaways

  • Patent Scope and Claims: Understanding the specific claims and scope of US Patent 8,686,034 is vital for navigating the intellectual property landscape in pharmaceutical chemistry.
  • Patent Landscape Analysis: Conducting a thorough analysis of prior art, related patents, and global filings helps in understanding the competitive environment.
  • Economic and Statistical Analysis: Utilizing datasets and studies on patent allowance rates provides valuable insights into the likelihood of patent approval and trends in patent scope.
  • Practical Implications: Knowledge of the patent's scope and claims is essential for avoiding infringement, licensing, and collaboration.

FAQs

What is the main subject of US Patent 8,686,034?

US Patent 8,686,034 pertains to a crystalline form of a γ-aminobutyric acid (GABA) analog and methods for its preparation.

How can I search for related patents?

You can use the USPTO's Patent Public Search tool, Global Dossier service, and international patent databases such as esp@cenet and PATENTSCOPE.

What is the significance of claim construction in patent analysis?

Claim construction is crucial for determining the scope of protection and for infringement analysis. It involves interpreting the meaning of the claims based on the language used, the specification, and any relevant prosecution history.

How can I access economic and statistical data related to patents?

The USPTO provides several datasets, including the Patent Claims Research Dataset, which contains detailed information on claims from US patents and published applications.

Why is it important to analyze the global patent landscape?

Analyzing the global patent landscape helps in identifying similar patents filed in other jurisdictions, understanding the competitive environment, and informing licensing and collaboration strategies.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,686,034

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No 8,686,034 ⤷  Subscribe TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS ⤷  Subscribe
Azurity HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No 8,686,034 ⤷  Subscribe MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS ⤷  Subscribe
Azurity HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-001 Apr 6, 2011 RX Yes Yes 8,686,034 ⤷  Subscribe MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS ⤷  Subscribe
Azurity HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-001 Apr 6, 2011 RX Yes Yes 8,686,034 ⤷  Subscribe TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,686,034

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 516801 ⤷  Subscribe
Australia 2004282192 ⤷  Subscribe
Brazil PI0415288 ⤷  Subscribe
Canada 2541752 ⤷  Subscribe
China 1867322 ⤷  Subscribe
Cyprus 1113583 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.